Prostate Cancer

Frank dela Rama explains the options available today, the limitations, and possibilities in the future for the diagnosis of prostate cancer.

Oncology navigator Frank dela Rama lists the screening tools available now for diagnosing prostate cancer.

Frank dela Rama talks about some of the stigma and miscommunication surrounding prostate cancer screening and the need for clarity.

Frank dela Rama explains the current recommendations for screening for prostate cancer.

A doctor’s mistake left Richard Churchill reeling, but during treatment for prostate cancer he found solace in nature and in many new relationships with patients, caregivers, and family members.

Here are the drugs and financial support services available to patients receiving treatment for Prostate Cancer.

On February 14, 2018, the FDA approved Erleada (apalutamide; from Janssen) for the treatment of patients with nonmetastatic, castration-resistant prostate cancer.

Here are the financial support services available to patients receiving treatment for Prostate Cancer.